No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Ernexa Therapeutics Announces New Data to Be Presented at AACR Annual Meeting 2025
12 Health Care Stocks Moving In Thursday's After-Market Session
Express News | Ernexa Therapeutics Inc Files Prospectus for Resale of 10.4 Mln Shares of Common Stock by Selling Stockholder- SEC Filing
Major Investment Alert: Eterna Therapeutics Sees Massive Share Purchase!
Eterna Therapeutics Insider Bought Shares Worth $394,174, According to a Recent SEC Filing
Ernexa Therapeutics Closes New Funding Round